Free tool
FAERS Monitor: Fragmin
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020287 or its brand name (Fragmin, Dalteparin Sodium). Reports on generic versions are filed under their own applications.
Reports
10,659
Serious
9,759
92% of reports
Hospitalization
5,540
Death reported
2,313
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea720
- off label use714
- pulmonary embolism618
- dyspnoea603
- vomiting586
- abdominal pain537
- sepsis513
- pyrexia501
- general physical health deterioration477
- diarrhoea461
- fatigue461
- anaemia458
- constipation457
- death422
- condition aggravated418
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 192 |
| 2005 | 182 |
| 2006 | 205 |
| 2007 | 233 |
| 2008 | 219 |
| 2009 | 339 |
| 2010 | 399 |
| 2011 | 505 |
| 2012 | 572 |
| 2013 | 390 |
| 2014 | 442 |
| 2015 | 477 |
| 2016 | 522 |
| 2017 | 472 |
| 2018 | 607 |
| 2019 | 641 |
| 2020 | 640 |
| 2021 | 859 |
| 2022 | 710 |
| 2023 | 667 |
| 2024 | 542 |
| 2025 | 446 |
| 2026 | 396 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,500 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pulmonary embolismSignal | 618 | 12.9 | 12.0 | 6,765 |
| sepsisSignal | 513 | 9.1 | 8.4 | 3,700 |
| general physical health deteriorationSignal | 477 | 8.2 | 7.5 | 2,996 |
| anaemiaSignal | 458 | 4.7 | 4.3 | 1,360 |
| abdominal painSignal | 537 | 4.6 | 4.2 | 1,504 |
| constipationSignal | 457 | 4.1 | 3.8 | 1,095 |
| pyrexiaSignal | 501 | 2.9 | 2.6 | 613 |
| condition aggravatedSignal | 418 | 2.7 | 2.5 | 457 |
| vomitingSignal | 586 | 2.5 | 2.3 | 518 |
| dyspnoeaSignal | 603 | 2.1 | 1.9 | 357 |
| nausea | 720 | 1.8 | 1.7 | 263 |
| off label use | 714 | 1.6 | 1.5 | 171 |
| diarrhoea | 461 | 1.4 | 1.3 | 56 |
| fatigue | 461 | 1.2 | 1.1 | 11 |
| death | 422 | 1.0 | 0.9 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.